Panagiota Goutakoli
Overview
Explore the profile of Panagiota Goutakoli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
15
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Neofotistou-Themeli E, Goutakoli P, Chanis T, Semitekolou M, Sevdali E, Sidiropoulos P
Front Med (Lausanne)
. 2025 Feb;
11:1376925.
PMID: 39906351
High-throughput technologies in human and animal studies have revealed novel molecular and cellular pathways involved in tissue inflammation of rheumatoid arthritis (RA). Fibroblasts have been in the forefront of research...
2.
Dedemadi A, Sevdali E, Georgiadou D, Valanti E, Neofotistou-Themeli E, Chanis T, et al.
Biochim Biophys Acta Mol Cell Biol Lipids
. 2025 Jan;
1870(2):159596.
PMID: 39842506
Human paraoxonase 1 (PON1), an enzyme bound to high-density lipoprotein (HDL), hydrolyzes oxidized lipids and contributes to HDL atheroprotective functions. Decreased serum paraoxonase and arylesterase activities of PON1 have been...
3.
Goutakoli P, Papadaki G, Repa A, Avgoustidis N, Kalogiannaki E, Flouri I, et al.
Cells
. 2023 Dec;
12(24).
PMID: 38132128
Abatacept (CTLA4-Ig)-a monoclonal antibody which restricts T cell activation-is an effective treatment for rheumatoid arthritis (RA). Nevertheless, only 50% of RA patients attain clinical responses, while predictors of response are...
4.
Flouri I, Goutakoli P, Repa A, Bertsias A, Avgoustidis N, Eskitzis A, et al.
Rheumatol Int
. 2023 Oct;
44(2):249-261.
PMID: 37815625
To characterize disease activity trajectories and compare long-term drug retention between rheumatoid (RA) and spondylarthritis (SpA) patients initiating tumor necrosis factor inhibitor (TNFi) treatment (etanercept). Prospective observational study of RA,...
5.
Papadaki G, Goutakoli P, Tiniakou I, Grun J, Grutzkau A, Pavlopoulos G, et al.
J Immunol
. 2022 Nov;
209(10):1906-1917.
PMID: 36426957
Rheumatoid arthritis (RA) is characterized by autoimmune joint destruction with debilitating consequences. Despite treatment advancements with biologic therapies, a significant proportion of RA patients show an inadequate clinical response, and...
6.
Senard T, Flouri I, Vuckovic F, Papadaki G, Goutakoli P, Banos A, et al.
Arthritis Res Ther
. 2022 Aug;
24(1):206.
PMID: 36008868
Background: Rheumatoid arthritis (RA) is a chronic autoimmune disease for which prediction of long-term prognosis from disease's outset is not clinically feasible. The importance of immunoglobulin G (IgG) and its...
7.
Drosopoulou E, Syllas A, Goutakoli P, Zisiadis G, Konstantinou T, Pangea D, et al.
Insects
. 2019 Dec;
10(12).
PMID: 31795125
is one of the approximately 100 sibling species of the complex and considered to be very closely related to . Due to their high morphological similarity and overlapping distribution, as...